We are a consultancy firm offering services focused on the application of quantitative approaches to support drug research, development, and life-cycle decisions with the overall aim to improve patients’ lives.

Our story began in 2012, when a team composed of experienced consultants, leaders from the pharmaceutical industry and researchers from Uppsala University formed Pharmetheus, Since then, our core business focus has broadened to support a wider range of model informed drug development (MIDD) activities across all phases of research and development and across a wide range of therapeutic areas. We continue to provide fit for purpose analyses and reports to support a wide variety of drug development decisions (such as dose selection, developing pediatric development plans, investigating the potential risk for QTc prolongation etc.).

Read more at www.pharmetheus.com

Life Sciences

Pharmetheus

Peter Milligan

Martina Lundgren

Teams at Pharmetheus

Data and Programming Team

Leadership Team